1-(4-(Chloromethyl)thiazol-2-yl)-N,N-dimethylmethanamine hydrochloride

Catalog No. :
ACDPBI601
CAS No. :
82586-71-8
Molecular Formula :
C7H12Cl2N2S
Molecular Weight :
227.16

IUPAC Name:1-(4-(chloromethyl)thiazol-2-yl)-N,N-dimethylmethanamine hydrochloride

1-(4-(Chloromethyl)thiazol-2-yl)-N,N-dimethylmethanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(Chloromethyl)thiazol-2-yl)-N,N-dimethylmethanamine hydrochloride
IUPAC Name1-(4-(chloromethyl)thiazol-2-yl)-N,N-dimethylmethanamine hydrochloride
Molecular FormulaC7H12Cl2N2S
Molecular Weight227.16
SMILESCN(C)CC1=NC(CCl)=CS1.[H]Cl
InChI KeyVJJZXQCIDAQYNQ-UHFFFAOYSA-N
Synonym4-(chloromethyl)-N,N-dimethyl-2-Thiazolemethanamine hydrochloride;N-{[4-(chloromethyl)-1,3-thiazol-2-yl]methyl}-N,N-dimethylamine hydrochloride;2-DIMETHYL AMINO METHYL-4-CHLORO METHYL THIAZOLE HCL;2-DIMETHYL AMINO METHYL-4-CHLORO METHYL THIAZOLE HYDROCHLORIDE;Nizatidine CMT Intermediate;1-[4-(chloromethyl)-1,3-thiazol-2-yl]-N,N-dimethylmethanamine,hydrochloride;2- ( NN-DIMETHYL AMINO METHYL )- 4-CHLOROMETHYL THIAZOLE HYDROCHLORIDE (CHLOROMETHYL THIAZOLE) [NI4]
CAS No.82586-71-8

Synthetic Route by SureRoute

1. ACDPBI601 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDPBI601 route product structure diagram
    ACDPBI60182586-71-8
Inquiry

2. ACDPBI601 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXKGF602 route compound structure diagram
    ACXKGF60227366-72-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDPBI601 route product structure diagram
    ACDPBI60182586-71-8
Inquiry

Comments (0)